Vanda Pharmaceuticals Announces Initiation of "CALYPSO" to Study the Role of Genetic Variation in COVID-19 Infections in Collaboration With University of Washington Medicine

Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
202-734-3400